Inhibitory effect of titanium particles on osteoclast formation generated by treatment of mouse bone marrow cells with PGE2

Oral Diseases

Volumn 9, Issue 2, 2003, Pages 77-83

  Nakano, M ^a   Tsuboi, T ^a   Kato, M ^a   Kurita, K ^a   Togari, Akifumi ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Mouse bone marrow cells; Osteoclastogenesis; Prostaglandin E2; RANKL; Titanium particles

Indexed keywords

CALCITRIOL; OSTEOCLAST DIFFERENTIATION FACTOR; PROSTAGLANDIN E2; TITANIUM;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; BONE MARROW CULTURE; BONE REMODELING; CELL ACTIVITY; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; SIGNAL TRANSDUCTION; SOLUBILITY;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; DINOPROSTONE; GLYCOPROTEINS; MALE; MICE; MICE, INBRED STRAINS; OSTEOCLASTS; OSTEOPROTEGERIN; RABBITS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TITANIUM;

EID: 0037362127     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1601-0825.2003.02904.x     Document Type: Article

References (44)

1. Algan SM, Purdon M, Horowitz SM (1996). Role of tumor necrosis factor alpha in particulate-induced bone resorption. J Orthop Res 14: 30-35.
2. Anderson DM, Maraskovsky E, Billingsley WL et al (1997). A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390: 175-179.
3. Bi Y, Seabold JM, Kaar SG et al (2001). Adherent endotoxin on orthopedic wear particles stimulates cytokine production and osteoclast differentiation. J Bone Miner Res 16: 2082-2091.
4. Blaine TA, Rosier AN, Puzas JE et al (1996). Increased levels of tumor necrosis factor-alpha and interleukin-6 protein and messenger RNA in human peripheral blood monocytes due to titanium particles. J Bone Joint Surg Am 78: 1181-1192.
5. Friedman RJ, Black J, Galante JO et al (1994). Current concepts in orthopeadic biomaterials and implant fixation. Inst Course Lect 43: 233-255.
6. Fuller K, Owens JM, Jagger CJ et al (1993). Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med 178: 1733-1744.
7. Gao YH, Shinki T, Yuasa T et al (1998). Potential role of cbfal, an essential transcriptional factor for osteoblast differentiation, in osteoclastgenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun 252: 696-702.
8. Glant TT, Jacobs JJ, Molnar G et al (1993). Bone resorption activity of particulate- stimulated macrophages. J Bone Miner Res 8: 1071-1079.
9. Glant TT, Jacobs JJ (1994). Response of three murine macrophage populations to particulate debris: bone resorption in organ cultures. J Orthop Res 12: 720-731.
10. Gonzales JB, Purdon MA, Horrowitz SM (1996). In vitro studies on the role of titanium in asptic loosening. Clin Orthop 330: 244-250.
11. Greenfield EM, Bi Y, Miyauchi A (1999). Regulation of osteoclast activity. Life Sci 65: 1087-1102.
12. Harada Y, Brown S, Merritt K et al (1995). Effect of metal particles and their corrosion products on human monocyte/ macrophages in vitro. Trans Orthop Res Soc 20: 776.
13. Herman JH, Sowder WG, Anderson D et al (1989). Polymethylmethacrylate-induced release of bone resorbing factors. J Bone Joint Surg Am 71: 1530-1541.
14. Hofbauer LC, Dunstan CR, Spelsberg TC et al (1998). Osteoprotegrin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenic protein-2, and cytokines. Biochem Biophys Res Commun 250: 776-781.
15. Horwood NJ, Elliott J, Martin TJ et al (1998). Osteotropic agents regulate the exopression of osteoclast differentiation factor and osteoprotegrin in osteoblastic stromal cells. Endocrinology 139: 4743-4746.
16. Jimi E, Shuto T, Koga T (1995). Macrophage colony-stimulating factor and interleukin-1 alpha maintain the survival of osteoclast-like cells. Endocrinology 136: 808-811.
17. Jimi E, Akiyama S, Tsurukai T et al (1999). Osteoclast differentiation factor acts as a multifunctional regulator in murine osteoclast differentiation and function. J Immunol 163:434-442.
18. Kane KR, Mochel DM, DeHeer DH et al (1994). Influence of titanium particle size on the in vitro activation of macrophages. Contemp Orthop 28: 249-261.
19. Kanehisa J, Yamanaka T, Doi S et al (1990). A band of F-actin containing podosomes is involved in bone resorption by osteoclasts. Bone 11: 287-293.
20. Kakudo S, Miyazawa K, Kameda T et al (1996). Isolation of highly enriched rabbit osteoclasts from collagen gel: a new assay system for bone-resorbing activity of mature osteoclasts. J Bone Miner Metab 14: 129-136.
21. Kim KJ, Itoh T, Takahashi M et al (1996). Activation of osteoclast-mediated bone resorption by the supernatant from a rabbit synovial cell line in response to polyethylene particles. J Biomed Mat Res 32: 3-9.
22. Kim KJ, Hijikata H, Itoh T et al (1998). Joint fluid from patients with failed total hip arthroplasty stimulates pit formation by mouse osteoclasts on dentin slices. J Biomed Mat Res 43: 234-240.
23. Lacey DL, Tan HL, Lu J et al (2000). Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 157: 435-448
24. Maloney WJ, James RE, Smith RL (1996). Human macrophage response to retrieved titanium alloy particles in vitro. Clin Orthop 322: 268-278.
25. Matsunaga T, Kojo T, Tsujisawa T et al (2001). Preferential degradation of osteoclasts by titanium tetrachloride. J Biomed Mat Res 55: 313-319.
26. Minkin C (1982). Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34: 285-290.
27. Murakami T, Yamamoto M, Ono K et al (1998). Transforming growth factor-β1 increases mRNA level of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells. Biochem Biophys Res Commun 252: 747-752.
28. Murray DW, Rushton N (1990). Macrophages stimulate bone resorption when they phagocytose particles. J Bone Joint Surg Br 72: 988-992.
29. Norrdin RW, Jee WSS, High WB (1990). The role of prostaglandins in bone in vivo. Prostaglandins Leukot Essent Fatty Acids 41: 139-150.
30. Pollice PF, Hsu J, Hicks DG et al (1998). Interleukin-10 inhibits cyrokine synthesis in monocytes stimulated by titanium particles: evidence of an anti-inflammatory regulatory pathway. J Orthop Res 16: 697-704.
31. Raisz LG, Fall PM (1990). Biphasic effects of prostaglandin E2 on bone formation in cultured fetal rat calvariae: interaction with cortisol. Endocrinology 126: 1654-1659.
32. Shanbhag AS, Jacobs JJ, Black J et al (1995). Human monocyte response to particulate biomaterials generated in vivo and in vitro. J Orthop Res 13: 792-801.
33. Simonet WS, Lacey DL, Dunstan CR et al (1997). Osteoprotegrin: a novel secreted protein involved in the regulation of bone density. Cell 89: 309-319.
34. Suda T, Takahashi N, Martin TJ (1992). Modulation of osteoclast differentiation. Endocr Rev 13: 66-80.
35. Suda T, Udagawa N, Nakamura I et al (1995). Modulation of osteoclast differentiation by local factors. Bone 17: 87S-91S.
36. Suda T, Udagawa N, Takahashi N (2000). The molecular mechanism of osteoclast differentiation and activation. Dent Jap 36: 42-46.
37. Takahashi N, Yamada H, Yoshiki S et al (1988). Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122: 1373-1382.
38. Takada Y, Kusuda M, Hiura K et al (1992). A simple method to assess osteoclast-mediated bone resorption using unfractionated bone cells. Bone Miner 17: 347-359.
39. Tsuda E, Goto M, Mochizuki S et al (1997). Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastgenesis. Biochem Biophys Res Commun 17: 137-142.
40. Vidal ON, Sjogren K, Eriksson BI et al (1998). Osteoprotegrin mRNA is increased by interleukin-1α in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells. Biochem Biophys Res Commun 248: 696-700.
41. Weyand CM, Geisler A, Brack A et al (1998). Oligoclonal T-cell proliferation and interferon-gamma production in periprosthetic inflammation. Lab Invest 78: 677-685.
42. Wong BR, Rho J, Arron J et al (1997). TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 272: 25 190-25 194.
43. Yasuda H, Shima N, Nakagawa N et al (1998a). Osteoclast differentiation factor is a ligand for osteoprotegrin osteoclastgenesis-inhibitory factor and is identical to TRANCE/ RANKL. Proc Natl Acad Sci USA 95: 3597-3602.
44. Yasuda H, Shima N, Nakagawa N et al (1998b). Identity of osteoclastgenesis inhibitory factor (OCIF) and osteoprotegrin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139: 1329-1337.